Ajax Health deploys capital and leverages operational experience to accelerate healthcare innovation across medical devices, digital health, healthcare services and biotechnology. We partner with entrepreneurs across all stages of a company's lifecycle and leverage deep domain expertise to support business strategy, clinical & regulatory, R&D and M&A.
Portfolio 1
| Date | Name | Website | Total Raised | Location |
| 14.05.2026 | UroMems | uromems.com | $151.85M | France |
Mentions in press and media 20
| Date | Title | Description |
| 14.05.2026 | UroMems: $60 Million Raised For Smart Implant Treating Stress Urinary Incontinence | UroMems announced a $60 million strategic investment from Ajax Health to continue funding pivotal clinical trials and commercial launch preparation for the UroActive System, the company’s smart automated implant designed to treat stress uri... |
| 04.11.2024 | Boston Scientific to acquire Cortex and its cardiac mapping tech | Boston Scientific (NYSE: BSX) announced today that it will purchase Ajax Health’s Cortex and its FDA-cleared OptiMap system to guide physicians performing ablation procedures to treat AFib Financial terms of the deal were not disclosed. Bos... |
| 15.05.2024 | Cortex Announces Appointment of Dr. Matthew Lungren, Chief Data Science Officer for Microsoft Health & Life Sciences, to its Board of Directors | Dr. Lungren brings expertise translating cutting-edge AI technology into valuable healthcare applications MENLO PARK, Calif., May 15, 2024 /PRNewswire/ -- Cortex, a medical technology company aiming to transform the diagnosis and treatment ... |
| 24.05.2021 | AcuityMD Nabs $7M for Targeting Platform for Medical Device Companies | What You Should Know: – AcuityMD, a platform for commercializing and improving medical devices with data announced it has raised $7M in funding led by Benchmark with participation from Ajax Health. Eric Vishria, General Partner at Benchmark... |
| 12.03.2021 | Cardinal Health : signs definitive agreement to sell its Cordis business to Hellman & Friedman | DUBLIN, Ohio, March 12, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately $1 billion, which includes ... |
| 12.03.2021 | CARDINAL HEALTH, INC. Cardinal Health : signs definitive agreement to sell its Cordis business to Hellman & Friedman | DUBLIN, Ohio, March 12, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately $1 billion, which includes ... |
| 12.03.2021 | Cardinal Health Signs Definitive Agreement to Sell its Cordis Business to Hellman & Friedman | March 12th, 2021 DUBLIN, Ohio Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately $1 billion, which includes buyer’s assum... |
| 12.03.2021 | Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman USA - English USA - English | |
| 30.09.2019 | Ajax Health Closes Third $100M MedTech Innovation Fund | Duke Rohlen, Chairman and CEO, Ajax Health – Ajax Health raises $100M to close third medtech innovation, Ajax3 led by HealthQuest Capital with participation from Polaris Partners. – Led by Duke Rohlen, Chairman and CEO, Ajax3 quickly follow... |
| 30.09.2019 | Ajax Health Raises $100M to Form Ajax 3 | Ajax Health, a Menlo Park, Calif.-based investor in the healthcare space, raised $100m to form Ajax 3. The capital will target investing in companies in the areas of medtech, healthcare services, and healthcare IT that focus on innovative a... |
Show more